Drugs Made In America Acquisition . Rights Stock Forecast

Sell candidate since Jun 05, 2026 Loss -0.99%

No changes to the price of Drugs Made In America Acquisition Corp. stock on the last trading day (Friday, 12th Jun 2026). During the last trading day the stock fluctuated 10.00% from a day low at $0.100 to a day high of $0.110. The price has fallen in 5 of the last 10 days and is down by -10.07% for this period.

Given the current short-term trend, the stock is expected to rise 83.50% during the next 3 months and, with a 90% probability hold a price between $0.184 and $0.334 at the end of this 3-month period.

DMAAR Signals & Forecast

There are few to no technical positive signals at the moment. The Drugs Made In America Acquisition Corp. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.104 and $0.114. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, May 07, 2026, and so far it has fallen -32.89%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Drugs Made In America Acquisition Corp. stock

On the downside, the stock finds support just below today's level from accumulated volume at $0.0900 and $0.0810. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Drugs Made In America Acquisition Corp. finds support just below today's level at $0.0900. If this is broken, then the next support from accumulated volume will be at $0.0810 and $0.0801.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.0100 between high and low, or 10.00%. For the last week the stock has had daily average volatility of 17.17%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (DMAAR) For The Upcoming Trading Day Of Monday 15th

For the upcoming trading day on Monday, 15th we expect Drugs Made In America Acquisition Corp. Rights to open at $0.103, and during the day (based on 14 day Average True Range), to move between $0.0925 and $0.108, which gives a possible trading interval of +/-$0.0151 (+/-16.28%) up or down from last closing price. If Drugs Made In America Acquisition Corp. Rights takes out the full calculated possible swing range there will be an estimated 16.28% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.0900 (10.00%) than the resistance at $0.120 (19.80%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Drugs Made In America Acquisition Corp. Rights stock A Buy?

The Drugs Made In America Acquisition Corp. stock holds several negative signals and despite the positive trend, we believe Drugs Made In America Acquisition Corp. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -1.802 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 15, 2026 - $0.103 ( 3.33%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk